Boost For Oral SERDs As Menarini/Radius’ Orserdu Becomes First Approved For Breast Cancer

Following US FDA Approval

 
• By Ayisha Sharma
  
Pair of hands on the red ground of a race track, with a white number one painted on it
Menarini And Radius Have Won The Race For The First Oral SERD • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip